The US Food and Drug Administration has started making rejection letters that pharmaceutical companies traditionally keep under wraps more easily available to investors and the public, a move with the ...
Jan 30 (Reuters) - Shares of Corcept Therapeutics (CORT.O), opens new tab fell 16% on Friday after a corrected "complete response letter" from the U.S. Food and Drug Administration showed the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results